Literature DB >> 9540278

Experimental autoimmune uveitis as animal model for human posterior uveitis.

V K Singh1, S Biswas, R Anand, S S Agarwal.   

Abstract

Uveitis is an intraocular inflammatory disease that mostly affects children and young adults. It is one of the major causes of blindness in young individuals in India and the world. It is responsible for about 10 per cent of total visual impairment. Unfortunately, etiological diagnosis is not evident in a majority of these patients. It is generally felt that autoimmune mechanism may be involved in so called 'idiopathic' cases which has led to search for the putative autoantigens in experimental animal models. It has been demonstrated that experimental autoimmune uveitis (EAU) can be elicited against several retinal proteins in rats, mice and sub-human primates. These include the S-antigen, a major protein on retinal photoreceptor cell, interphotoreceptor retinoid binding protein (IRBP) and several others. There are many similarities between clinical entities and the EAU, but the EAU differs from the clinical conditions in being self-limited, and requiring complete Freund's adjuvant for induction of the disease. The disease can be induced only in susceptible strains. Nevertheless, use of the EAU model has allowed for identification of disease causing epitopes of antigens and evaluation of disease modifying strategies which could be applied in clinical situations. There has been significant progress in this field, but still a lot more is required to be learnt to translate it into clinical practice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540278

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  8 in total

Review 1.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

Review 3.  Modulation of autoimmune diseases by nitric oxide.

Authors:  V K Singh; S Mehrotra; P Narayan; C M Pandey; S S Agarwal
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

4.  Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.

Authors:  Fengqi An; Qing Li; Zhidan Tu; Hong Bu; Chi-Chao Chan; Rachel R Caspi; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

5.  Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.

Authors:  H Yang; S Zheng; Y Mao; Z Chen; C Zheng; H Li; C Sumners; Q Li; P Yang; B Lei
Journal:  Clin Exp Immunol       Date:  2015-11-17       Impact factor: 4.330

6.  Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.

Authors:  Tingyu Qin
Journal:  Mol Vis       Date:  2011-12-29       Impact factor: 2.367

7.  Photopic light-mediated down-regulation of local α1A-adrenergic signaling protects blood-retina barrier in experimental autoimmune uveoretinitis.

Authors:  Andrea Stofkova; Daisuke Kamimura; Takuto Ohki; Mitsutoshi Ota; Yasunobu Arima; Masaaki Murakami
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

8.  Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.

Authors:  Hongxia Yang; Shijie Zheng; Yiguo Qiu; Yan Yang; Chaokui Wang; Peizeng Yang; Qiuhong Li; Bo Lei
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-28       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.